About Henry Ford Cancer

A National Leader in Personalized Cancer Care

Henry Ford Cancer is one of the largest cancer institutions in Michigan, treating more than 9,500 new cancer patients each year. We offer a variety of services to provide the best care for our patients and their families from diagnosis through survivorship, including:

More than 1,400 team members, including fellowship trained cancer experts, researchers and nurse navigators, provide care in our five hospitals and multiple outpatient locations in southeast and south central Michigan. Henry Ford Cancer is anchored by our flagship Henry Ford Hospital in Detroit, which is nationally recognized for clinical excellence and innovation in the of treatment for prostate, brain tumors, breast and lung cancers.

Our Mission and Approach

As part of that promise, we’re building the Brigitte Harris Cancer Pavilion, a 187,000-square-foot cancer facility in Detroit for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced support services for cancer patients.

When it comes to facing cancer, our patients benefit from a strong, unified team approach. Our doctors are specialists in all forms of cancer, from rare conditions to more common. Every patient receives personalized treatment designed specifically for their unique cancer.

Precision Medicine

We are the only cancer program in Michigan to offer precision medicine testing to all cancer patients.

Powered by the success of our recent White House Cancer Moonshot visit – and the selection of Henry Ford by the National Institutes of Health as one of only seven sites in the country leading a molecular genetic "All for Us" screening program – our Precision Medicine Program is quickly becoming the largest program of its kind in the state.

Advanced Clinical Care Education and Training

We are training the next generation of cancer specialists from undergraduate and graduate students, to post-doctoral fellows. Our training extends to educational conferences and annual research symposiums, including those focused on breast, head and neck, urologic, and kidney cancers.

Top-Ranked Cancer Research

Our researchers apply their findings to clinical practice quickly - resulting in new, effective patient treatment. We rank 17th among independent hospitals in the U.S. in funding from the National Institutes of Health.

• Our cancer researchers receive about $25 million in external grants annually
• We host the world’s second-largest brain tumor bank, as well as a significant biorepository for precision medicine.
• We are making significant advances in the following areas: disparities and population health research, prostate cancer, gynecological cancers, brain cancer, radiation oncology, radiology, and drug discovery.